ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Jazz Pharmaceuticals Submits MAA to European Medicines Agency for Solriamfetol
November 10, 2018Jazz Pharmaceuticals announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, as a treatment to improve wakefulness and reduce ex -
Jazz Pharmaceuticals Submits MAA to European Medicines Agency for Solriamfetol
November 10, 2018Jazz Pharmaceuticals announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor, as a treatment to improve wakefulness and reduce ex
Pharma Sources Insight January 2025
